Skip to Content

Acuvail Approval History

  • FDA approved: Yes (First approved July 22nd, 2009)
  • Brand name: Acuvail
  • Generic name: ketorolac tromethamine
  • Dosage form: Ophthalmic Solution
  • Company: Allergan, Inc.
  • Treatment for: Postoperative Ocular Inflammation

Acuvail (ketorolac tromethamine) is a preservative-free formulation of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of pain and inflammation following cataract surgery.

Development History and FDA Approval Process for Acuvail

DateArticle
Jul 23, 2009Approval Allergan Receives FDA Approval for Acuvail Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide